Products & Programs PharmacyMedicaidJune 27, 2023

IV Iron Medical Step Therapy Notice

New specialty pharmacy medical step therapy requirements

Effective for dates of service on and after August 1, 2023, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process. Step therapy review will apply upon prior authorization initiation or renewal in addition to the current medical necessity review of all drugs noted below. 

The list of Clinical Criteria is publicly available on our provider website. Visit the Clinical Criteria website to search for specific Clinical Criteria.

Clinical Criteria

Status

Drug

HCPCS or CPT® code(s)

CC-0182

Non-preferred

Infed (iron dextran)

J1750

CC-0182

Non-preferred

Injectafer (ferric carboxymaltose)

J1439

CC-0182

Non-preferred

Monoferric (ferric derisomaltose)

J1437

CC-0182

Preferred

* Feraheme (ferumoxytol)

Q0138

CC-0182

Preferred

Ferrlecit (sodium ferric gluconate/sucrose complex)

J2916

CC-0182

Preferred

Venofer (iron sucrose)

J1756

* Feraheme (ferumoxytol) will change to preferred for both brand and generic.

Availity Essentials* Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to availity.com and select the appropriate payer space tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat.

For additional support, visit the Contact Us section at the bottom of our provider website for the appropriate contact.

* Availity, LLC is an independent company providing administrative support services on behalf of the health plan.

KYBCBS-CD-018622-23-CPN18331

PUBLICATIONS: August 2023 Provider Newsletter